Ivan D. Montoya MD, MPH

Dr. Montoya is a psychiatrist and epidemiologist who specializes in the development of therapeutics for Substance Use Disorders (SUDs). He provides programmatic oversight for grants and contracts in the Division of Therapeutics and Medical Consequences at the National Institute on Drug Abuse and manages activities and resources of the Division involved in the research of new therapeutics and the medical consequences of SUDs. He also provides medical oversight to grants and contracts and supports NIDA’s implementation of NIH-wide policies for the Clinical Trials Stewardship Initiative.

Dr. Montoya leads NIDA’s marijuana medications development initiative and the recently-published funding opportunity for the development of medications to prevent opioid use disorders and overdose, which is part of the NIH’s Public-Private Partnership to combat the opioid use crisis. He collaborates with the Intramural Research Project, with NIDA’s International Office in the Latin American Initiative, and is a member of several scientific interest workgroups. Previous experience includes seven years as a clinical investigator in the Intramural Research Program of NIDA, and four years in academia. He joined NIDA in December 1999.